Veterinary teams enhance feline diabetes management through personalized care, effective communication, and evolving treatment options for improved quality of life.
Feline diabetes mellitus (feline DM) has been recognized in veterinary medicine since the 1970s, with a significant increase in prevalence correlated with trends in feline obesity and sedentary lifestyles, particularly noted since the 1990s.
While the veterinary field has managed feline diabetes for several decades, it was not until the early 2000s that synthetic long-acting insulin analogs such as glargine (Lantus; Sanofi) and detemir (Levemir; Novo Nordisk) became widely utilized.
These formulations have contributed significantly to improved glycemic regulation and quality of life in diabetic feline patients.
Author summary: Veterinary teams improve feline diabetes care.